A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost-Effectiveness Analysis

被引:17
作者
Djalalov, Sandjar [1 ,2 ,3 ]
Beca, Jaclyn [4 ]
Ewara, Emmanuel M. [5 ]
Hoch, Jeffrey S. [6 ]
机构
[1] Westminster Int Univ Tashkent, 12 Istiqbol St, Tashkent 100047, Uzbekistan
[2] Tashkent Pharmaceut Inst, 45 Aybek St, Tashkent 100015, Uzbekistan
[3] Toronto Gen Hosp, Toronto Hlth Econ & Technol Assessment THETA Coll, Eaton Bldg,10th Floor,Room 248,200 Elizabeth St, Toronto, ON M5G 2C4, Canada
[4] Canc Care Ontario, Toronto, ON, Canada
[5] Janssen Inc, 19 Green Belt Dr, Toronto, ON M3C 1L9, Canada
[6] Univ Calif Davis, Dept Publ Hlth Sci, Div Hlth Policy & Management, Davis, CA 95616 USA
关键词
ECONOMIC EVALUATIONS;
D O I
10.1007/s40273-019-00830-4
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives The aim of this study was to use Microsoft Excel spreadsheet software to fit parametric survival distributions. We also explain the differences between individual patient data (IPD) and survival data reconstructed in Excel and SAS. Methods Three sets of patient data on overall survival were compared using different methods: 'original' IPD, 'reconstructed SAS', and 'reconstructed Excel'. The best-fit distribution was selected using visual observation, supported by linear plots of predicted probabilities, goodness-of-fit coefficients, and the sum of squared error of prediction. Outcomes included the incremental cost-effectiveness ratio (ICER), incremental net benefit (INB), incremental cost, and life-years gained over short-term and lifetime horizons. These were compared for different data sets. Results In this example, log-normal, log-logistic, and Weibull distributions showed best-fit with the visual tests and goodness-of-fit statistics. Weibull and exponential distributions showed significant differences compared with IPD data. Data on short-term (5 years) time horizons produced by different data re-creation methods showed closeness with data reconstructed from SAS. The ICER and INB results were dependent on the time horizon and selected parametric distribution from the model. Conclusions Different approaches used in fitting parametric survival distributions yielded predicted probabilities that substantially differed from those using original IPD. Our study highlights the importance of following guidelines for economic evaluations with a systematic approach to parametric survival analysis techniques in order to select best fitting parametric survival distributions.
引用
收藏
页码:1525 / 1536
页数:12
相关论文
共 15 条
[1]  
CADTH, 2017, Guidelines for the economic evaluation of health technologies: Canada
[2]   The "Hazards" of Extrapolating Survival Curves [J].
Davies, Charlotte ;
Briggs, Andrew ;
Lorgelly, Paula ;
Garellick, Goran ;
Malchau, Henrik .
MEDICAL DECISION MAKING, 2013, 33 (03) :369-380
[3]   Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial [J].
Diaby, Vakaramoko ;
Adunlin, Georges ;
Montero, Alberto J. .
PHARMACOECONOMICS, 2014, 32 (02) :101-108
[4]  
Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794
[5]   Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves [J].
Guyot, Patricia ;
Ades, A. E. ;
Ouwens, Mario J. N. M. ;
Welton, Nicky J. .
BMC MEDICAL RESEARCH METHODOLOGY, 2012, 12
[6]   Improved curve fits to summary survival data: application to economic evaluation of health technologies [J].
Hoyle, Martin W. ;
Henley, William .
BMC MEDICAL RESEARCH METHODOLOGY, 2011, 11
[7]   Overview of Parametric Survival Analysis for Health-Economic Applications [J].
Ishak, K. Jack ;
Kreif, Noemi ;
Benedict, Agnes ;
Muszbek, Noemi .
PHARMACOECONOMICS, 2013, 31 (08) :663-675
[8]  
Ishak KJ, 2011, PARAMETRIC SURVIVAL
[9]   Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis [J].
Khor, Sara ;
Beca, Jaclyn ;
Krahn, Murray ;
Hodgson, David ;
Lee, Linda ;
Crump, Michael ;
Bremner, Karen E. ;
Luo, Jin ;
Mamdani, Muhammad ;
Bell, Chaim M. ;
Sawka, Carol ;
Gavura, Scott ;
Sullivan, Terrence ;
Trudeau, Maureen ;
Peacock, Stuart ;
Hoch, Jeffrey S. .
BMC CANCER, 2014, 14
[10]   Survival Analysis for Economic Evaluations Alongside Clinical Trials-Extrapolation with Patient-Level Data: Inconsistencies, Limitations, and a Practical Guide [J].
Latimer, Nicholas R. .
MEDICAL DECISION MAKING, 2013, 33 (06) :743-754